ArticleJACC. Case reports2025
Temporary Extracorporeal Bypass System for Prevention of Acute Limb Ischemia From Percutaneous Ventricular Assist Device.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Hidden Vulnerability: How Underlying SMA Stenosis Turns Routine Intra-Aortic Balloon Pump Support Into Fatal Mesenteric Ischemia.Case reports in critical care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Impella CP device provides vital mechanical circulatory support in cardiogenic shock but carries a risk of acute limb ischemia, particularly in patients with peripheral artery disease. CASE SUMMARY: A 70-year-old woman with acute ST-segment elevation myocardial infarction experienced cardiogenic shock, requiring Impella CP support. After implantation, she was at high risk for acute limb ischemia. To maintain distal perfusion, a temporary extracorporeal bypass system was created using femoral artery sheaths and connecting tubing. She remained in stable condition without ischemic complications. The Impella CP and bypass system were successfully removed after hemodynamic recovery. DISCUSSION: Acute limb ischemia is a serious complication of Impella use. This case highlights that a temporary bypass system is an effective intervention to prevent limb loss in high-risk patients. TAKE-HOME MESSAGES: Timely recognition and intervention can prevent limb ischemia in Impella-supported patients. Temporary bypass circuits provide a practical solution to maintain distal perfusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.